Triple
T2190672
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Xarelto |
E49852
|
entity |
| Predicate | hasBioavailability |
P37223
|
FINISHED |
| Object | high oral bioavailability at lower doses |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: high oral bioavailability at lower doses | Statement: [Xarelto, hasBioavailability, high oral bioavailability at lower doses]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasBioavailability Context triple: [Xarelto, hasBioavailability, high oral bioavailability at lower doses]
-
A.
isProdrugOf
Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
-
B.
hasRouteOfAdministration
Indicates that one entity specifies the method or pathway by which another entity (typically a substance or medication) is administered.
-
C.
hasDosageForm
Indicates the specific physical form or presentation in which a drug or medicinal product is supplied or administered (e.g., tablet, injection, cream).
-
D.
isPegylated
Indicates that a molecule, typically a drug or therapeutic agent, has been chemically modified by the attachment of polyethylene glycol (PEG) chains.
-
E.
isExtendedReleaseFormulationOf
Indicates that one pharmaceutical formulation is an extended-release version of another, designed to release the active ingredient more slowly over time.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
| PDg | Predicate description generation | batch_69abbf9c77fc8190a323bcaf644fb2c5 |
completed | March 7, 2026, 6:03 a.m. |
Created at: March 4, 2026, 7:46 p.m.